Effect of RAAS blockers on adverse clinical outcomes in high CVD risk subjects with atrial fibrillation: A meta-analysis and systematic review of randomized controlled trials

Recent studies have demonstrated that atrial fibrillation significantly increases the risk of adverse clinical outcomes in high cardiovascular disease risk subjects. Application of renin–angiotensin–aldosterone system blockers for prevention of recurrence of atrial fibrillation and adverse clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaugai, Sandip, Sherpa, Lhamo Yanchang, Sepehry, Amir A., Arima, Hisatomi, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937957/
https://www.ncbi.nlm.nih.gov/pubmed/27368043
http://dx.doi.org/10.1097/MD.0000000000004059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937957/
https://www.ncbi.nlm.nih.gov/pubmed/27368043
http://dx.doi.org/10.1097/MD.0000000000004059

Ejemplares similares